Merck & Co Inc (6MK) Stock Price & News

Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products. The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000. In 1891, Merck & Co. was established as the American affiliate of the Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia

About Merck & Co Inc

CEOრობერ ემ დავის

Employees74 ათ.

Founded1 იან. 1891

Headquarters-

SectorPharmaceutical industry

Websitemerck.com

Revenue

Net income

All values in USD	სექ. 2025	დეკ. 2025	მარ. 2026	ივნ. 2026
Revenue	17,28 მლრდ.	16,40 მლრდ.	16,29 მლრდ.	16,61 მლრდ.
Cost of goods sold	3,74 მლრდ.	4,30 მლრდ.	3,88 მლრდ.	4,13 მლრდ.
Cost of revenue	3,74 მლრდ.	4,30 მლრდ.	3,88 მლრდ.	4,13 მლრდ.
Research and development expenses	4,00 მლრდ.	4,00 მლრდ.	3,56 მლრდ.	9,74 მლრდ.
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2,48 მლრდ.	2,73 მლრდ.	2,57 მლრდ.	2,78 მლრდ.
Operating expense	6,48 მლრდ.	6,73 მლრდ.	6,12 მლრდ.	12,52 მლრდ.
Total operating expenses	10,23 მლრდ.	11,02 მლრდ.	10,00 მლრდ.	16,65 მლრდ.
Operating income	7,05 მლრდ.	5,38 მლრდ.	6,29 მლრდ.	-40,00 მლნ.
Other non operating income	-	41,00 მლნ.	42,00 მლნ.	59,00 მლნ.
EBT including unusual items	6,74 მლრდ.	3,42 მლრდ.	-3,53 მლრდ.	-683,00 მლნ.
EBT excluding unusual items	6,76 მლრდ.	4,98 მლრდ.	5,85 მლრდ.	-508,00 მლნ.
Income tax expense	958,00 მლნ.	458,00 მლნ.	709,00 მლნ.	654,00 მლნ.
Effective tax rate	14,20%	13,39%	-20,06%	-95,75%
Other operating expenses	-	-	-	-
Net income	5,78 მლრდ.	2,96 მლრდ.	-4,24 მლრდ.	-1,34 მლრდ.
Net profit margin	33,49%	18,07%	-26,03%	-8,04%
Earnings per share	2,58	2,04	-1,28	-0,13
Interest and investment income	96,00 მლნ.	69,00 მლნ.	35,00 მლნ.	35,00 მლნ.
Interest expense	-327,00 მლნ.	-411,00 მლნ.	-479,00 მლნ.	-525,00 მლნ.
Net interest expenses	-231,00 მლნ.	-342,00 მლნ.	-444,00 მლნ.	-490,00 მლნ.
Depreciation and amortization charges	-	-	-	-
EBITDA	8,15 მლრდ.	6,79 მლრდ.	7,69 მლრდ.	1,43 მლრდ.
Gain or loss from assets sale	-	-	-	-

Ask anything